(Q36964971)

17 August 2017

Blood glucose levels in patients with metastatic renal cell carcinoma treated with sunitinib (English)

1 reference

metastatic renal cell carcinoma

17 August 2017

1 reference

1 reference

B Billemont

1

1 reference

17 August 2017

J Medioni

2

1 reference

17 August 2017

L Taillade

3

1 reference

17 August 2017

D Helley

4

1 reference

17 August 2017

J B Meric

5

1 reference

17 August 2017

O Rixe

6

1 reference

17 August 2017

S Oudard

7

1 reference

17 August 2017

language of work or name

English

0 references

publication date

7 October 2008

1 reference

British Journal of Cancer

17 August 2017

1 reference

17 August 2017

99

1 reference

17 August 2017

9

1 reference

17 August 2017

1380-1382

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604709

17 August 2017

0 references

cites work

Mechanisms of disease: using genetically altered mice to study concepts of type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579676

Molecular basis for sunitinib efficacy and future clinical development

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579676

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579676

Amelioration of diabetes by imatinib mesylate (Gleevec): role of beta-cell NF-kappaB activation and anti-apoptotic preconditioning

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579676

Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579676

Sunitinib in patients with metastatic renal cell carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579676

Remission of diabetes while on sunitinib treatment for renal cell carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579676

VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579676

Imatinib and regression of type 2 diabetes

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2579676

Non-islet-cell tumor induced hypoglycemia in patients with advanced gastrointestinal stromal tumor possibly worsened by imatinib

4 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18841151

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Macrocytosis and cobalamin deficiency in patients treated with sunitinib

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18841151

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18841151

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/SJ.BJC.6604709

1 reference

17 August 2017

1 reference

17 August 2017

1 reference